Quick Answer
GeneDx Holdings Corp. reported Net Income Loss of -$21.02 million for the year ending 2025.
- GeneDx Holdings Corp. showed an increase of +59.8% in Net Income Loss from 2024 to 2025.
- This data is from GeneDx Holdings Corp.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), GeneDx Holdings Corp.'s Net Income Loss has grown by 29.2%.
- Historical annual values: Fiscal year 2025: -$21.02 million | Fiscal year 2024: -$52.29 million | Fiscal year 2023: -$175.77 million | Fiscal year 2022: -$548.98 million | Fiscal year 2021: -$245.39 million | Fiscal year 2020: -$241.34 million | Fiscal year 2019: -$29.70 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: